November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
July 03, 2015
Finland's decision to deny entry to Duma Chairman Naryshkin surprised Russia - Foreign Ministry
Russian, Chinese PMs discuss bilateral agenda, upcoming contacts in telephone talk
U.S. embassy declines to say whether State Department served process on Russian govt regarding Yukos case
Poroshenko introduces new Security Service chief to its staff
Russian, S. African Navy chiefs discuss cooperation at meeting in St. Petersburg
Member of Khattab gang which killed 15 soldiers in Chechnya in 1999 jailed for ten years
Ukraine seeking to open intl probe into Gazprom's gas supply to Donbas - Naftogaz CEO
Poroshenko vows unhindered passage of humanitarian cargo
No reason to reschedule Oct 18 elections, we act within Minsk agreements - Pushilin
Naftogaz chief expecting next round of gas talks as early as July
If Biden is worried about fate of Minsk accords, he should get Kyiv to comply with them - Zakharchenko
Members of Ukrainian volunteer battalions demand resuming fighting in Donbas at rally in Kyiv
Chubais satisfied with investigators' decision not to detain Melamed